Literature DB >> 240846

Characteristics of a pyrimidine-specific 5'-nucleotidase in human erythrocytes.

D E Paglia, W N Valentine.   

Abstract

A 5'-nucleotidase with unique specificity has been identified in the soluble fraction of normal human erythrocytes. It mediates the hydrolytic dephosphorylation of pyrimidine 5'-ribosemonophosphates but is catalytically ineffective with purine nucleotides or with the 2'-, 3'-, or cyclic isomers of pyrimidine nucleotides. Activities at 37 degrees in dialyzed hemolysates of nromal human erythrocytes averaged 7.3 and 6.2 mumol of Pi liberated per hour per g of hemoglobin for the substrates UMP and CMP, respectively. Activity with TMP as substrate was approximately one-half as much as with UMP or CMP. Apparent Michaelis constants were 0.33 mM UMP, 0.15 mM CMP, and 1.0 mM TMP. Magnesium was required for optimal activity, and this cation could not be replaced by Mn2+. Maximum activity was obtained between pH 7.0 and 7.5 with rapid decreases in more alkaline media and moderate decreases with acidification. The enzyme was quite sensitive to heat and was strongly inhibited by AMP, by some purine bases, and by both purine and pyrimidine nucleosides. Divalent cations of heavy metals were also strongly inhibitory, as were agents active against sulfhydryl groups. The presence of substrates and/or 2-mercaptoethanol provided considerable protection against some of these deleterious agents and conditions. Pyrimidine 5'-nucleotidase activity in hemolysates was clearly distinguishable from erythrocyte acid phosphatase and from leukocyte and serum alkaline phosphatases and nucleotidases.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240846

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics.

Authors:  George N Phillips; Brian G Fox; John L Markley; Brian F Volkman; Euiyoung Bae; Eduard Bitto; Craig A Bingman; Ronnie O Frederick; Jason G McCoy; Betsy L Lytle; Brad S Pierce; Jikui Song; Simon N Twigger
Journal:  J Struct Funct Genomics       Date:  2007-09-06

2.  Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5'-nucleotidase.

Authors:  R Rosa; H Rochant; B Dreyfus; C Valentin; J Rosa
Journal:  Hum Genet       Date:  1977-09-22       Impact factor: 4.132

3.  Determination of erythrocyte pyrimidine 5'-nucleotidase activity by 31P nuclear magnetic resonance: comparison of normal controls and multiple sclerosis patients.

Authors:  G L Mendz; C R Middlehurst; P W Kuchel; P A Crossie
Journal:  Experientia       Date:  1986-09-15

4.  Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.

Authors:  A De Flora; E Zocchi; L Guida; C Polvani; U Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Purification and properties of human erythrocyte pyrimidine 5'-nucleotidase.

Authors:  J D Torrance; D Whittaker; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.

Authors:  W N Valentine; D E Paglia; K Fink; G Madokoro
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

7.  Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.

Authors:  A Pagliuca; G J Mufti; D Baldwin; A N Lestas; R M Wallis; A J Bellingham
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

8.  Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.

Authors:  Pinar Aksoy; Min Jia Zhu; Krishna R Kalari; Irene Moon; Linda L Pelleymounter; Bruce W Eckloff; Eric D Wieben; Vivien C Yee; Richard M Weinshilboum; Liewei Wang
Journal:  Pharmacogenet Genomics       Date:  2009-08       Impact factor: 2.089

9.  Comparative study of effects of lead on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in vivo and in vitro.

Authors:  K Tomokuni; M Ogata
Journal:  Arch Toxicol       Date:  1980-09       Impact factor: 5.153

10.  Isolation and partial characterization of a 5'-nucleotidase specific for orotidine-5'-monophosphate.

Authors:  M H El Kouni; S Cha
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.